Embed Size (px)
DESCRIPTION
Education & Advocacy: Building Local Capacity to Prevent Rx Drug Abuse -
Citation preview
Educa&on & Advocacy Track: Building Local Capacity to Prevent Rx Drug Abuse
Presenters:
Terry Cline, PhD, Commissioner of Health, Oklahoma Secretary of Health and Human Services, ASTHO President
Gregg Raduka, PhD, LPC, ICPS, Director of Preven&on/ Interven&on, The Council on Alcohol and Drugs
Christopher Wood, ICPS, Georgia DBHDD/Office of Preven&on
Moderator: Regina M. LaBelle, JD, Chief of Staff, White House Office of Na&onal Drug Control Policy
Disclosures
• Terry Cline has no financial rela2onships with proprietary en22es that produce health care goods and services.
• Gregg Raduka has no financial rela2onships with proprietary en22es that produce health care goods and services.
• Christopher Wood has no financial rela2onships with proprietary en22es that produce health care goods and services.
Learning Objec2ves
1. Iden2fy three policy and/or programma2c approaches to prevent prescrip2on drug misuse, abuse, and diversion toward the long-‐term improvement of health outcomes.
2. Describe the role of state health agencies in working with other state governmental en22es and in enhancing collabora2on with tradi2onal and non-‐tradi2onal partners.
3. Build replicable ac2vi2es to form, sustain and engage an ac2ve, statewide Rx preven2on collabora2ve.
Panel Session: Building Local Capacity to Prevent Rx Drug Abuse Wednesday, April 23, 2014; 1:30 – 2:45 p.m.
Terry Cline, PhD Commissioner of Health
Oklahoma Secretary of Health and Human Services ASTHO President
Panel Session: Building Local Capacity to Prevent Rx Drug Abuse Wednesday, April 23, 2014; 1:30 – 2:45 p.m.
Terry Cline has no financial relationships with proprietary entities that produce health
care goods and services.
Source: CDC. Vital Signs: Overdoses of Prescription Opioid Pain Relievers—United States, 1999-2008. CDC Policy Impact: Prescription Painkiller Overdoses. Available at:
www.cdc.gov/homeandrecreationalsafety/rxbrief/
American Academy of Pain Management American Pharmacists Association American Association of Poison Control Centers American Society of Addiction Medicine PDMP Center of Excellence (Brandeis University) Centers for Disease Control and Prevention Clinton Foundation Federation of State Medical Boards Kanawha-Charleston Health Department Maryland Poison Control Center National Alliance for Model State Drug Laws National Association of Chain Drug Stores National Association of County and City Health Officials National Association of State Alcohol and Drug Abuse Directors National Governors Association National Institute on Drug Abuse Office of the Army Surgeon General Ohio Department of Health Oklahoma State Department of Health Pennsylvania Department of Drug and Alcohol Programs
Personal Advocate Pharmaceutical Research and Manufacturers of America Project Lazarus Safe States Alliance Substance Abuse and Mental Health Services Administration Tennessee Department of Health United States Department of Justice University of Kansas School of Medicine University of Rochester Medical Center Vermont Department of Health White House Office of National Drug Control Policy
Ongoing Work: Expand and Strengthen Key Partnerships
and Collaborative Infrastructure
Prioritize multi-sector efforts and identify collaborations, partnerships, stakeholders, and corresponding efforts to address prescription drug abuse.
Goal: Improve health outcomes and reduce human and economic costs associated with prescription drug misuse, abuse, and overdose.
Pledge: Reduce the rate of nonmedical use and the number of unintentional overdose deaths involving controlled prescription drugs* 15 percent by 2015.
*(including opioid analgesics, stimulants, tranquilizers, and sedatives)
Encourages all S/THOs to apply strategies to achieve measurable reductions in controlled prescription drug misuse, abuse, and overdose
Identify at least one policy or program to implement, improve, or evaluate in the next year
Move beyond “silo-based” approaches to focus on collaboration with partners to carry out aligned, comprehensive efforts
Metric TennCare Paid Live Births1 TennCare non-
LBWT Births TennCare Live LBWT Births2 NAS Infants
Number of Births 45,205 40,437 4,768 528 Cost for Infant in First Year of Life $350,936,293 $171,336,964 $179,599,329 $33,249,612 Average Cost per Child $7,763 $4,237 $37,668 $62,973 Average Length of Stay (days) 4.8 3.2 18.3 32.5
1 This sample contains only children that were directly matched to TennCare’s records based on Social Security Number. 2 Any infant weighing under 2,500g at the time of birth was considered low birth weight (LBWT).
Infants Born in CY 2011 NAS Infants Total # of Infants 55,578 528 Total # Infants in DCS 767 120 % in DCS 1.4% 22.7%
Percentage of Newborns in DCS Custody within One Year of Birth, CY 2011
Impact of NAS on Infant Health Care Expenditures, CY 2011
Source: Ohio Department of Alcohol and Drug Addiction Services SFY 2012 Annual Report
This map uses hot spot analysis to display the number of clients in treatment who list heroin (left), prescription opioids (right) as a
primary drug of choice by zipcode.
September 2012 – Governor Mary Fallin’s Prescription Drug Task Force Created
February 2013 – Finalized State Plan
October 2013 – Distributed Opioid Prescribing Guidelines
December 2013 – Governor’s Launch of Plan and Media Campaign
April 2014 – Naloxone Program Begins
HB 1781 – Prescription Drug Monitoring Program (PDMP) Access Grants the Department of Health and the Department of Mental Health and Substance Abuse Services access to PDMP; shared data may be used for statistical, research, substance abuse prevention provided that confidentiality is maintained.
HB 1782 – Naloxone Allows first responders to administer opiate antagonists without a prescription when encountering a person exhibiting signs of a drug overdose, and allows prescriptions to family members so they can administer in an overdose situation.
HB 1783 – Emergency Rule Changes Hydrocodone Refills Limits hydrocodone refills with no automatic refills; new prescription required.
$1.2 million appropriated specifically for prescription drug initiatives annually
As of 04/09/2014, 27 states and one territory have accepted the Challenge!
www.astho.org/rx
BUILDING LOCAL CAPACITY National Rx Drug Abuse Summit
April 23, 2014 Gregg Raduka, Ph.D., LPC, ICPS
Director of Prevention/Intervention The Council on Alcohol and Drugs
Disclaimer: Dr. Gregg Raduka has no
financial rela&onships with proprietary en&&es that produce health care goods
and services.
Learning Objectives of Dr. Raduka’s Presentation will
enable attendees to: 1. Iden2fy three policy and/or programma2c approaches to prevent prescrip2on drug misuse, abuse, and diversion toward the long-‐term improvement of health outcomes. 2. Build replicable ac2vi2es to form, sustain and engage an ac2ve, statewide Rx preven2on collabora2ve.
Funded by the Georgia Department of Behavioral Health and Developmental Disabilities (DBHDD), Office of Prevention Services & Programs
Services based on 4 Office of Na&onal Drug Control Policy (ONDCP) priority areas:
Educa&on Advocacy/ Enforcement Safe Storage and Secure Disposal
Uses 5 Steps of Strategic Preven&on Framework Needs Assessment / Capacity Building / Planning / Implementa&on / Evalua&on
The Ins&tute of Public Health at Georgia State University, in concert with the Ini&a&ve, published a statewide Needs Assessment re: Rx drug abuse in Georgia during Year 01.
Tip: Not all Evaluators can do Needs Assessments.
Needs Assessment
Georgia Prescrip&on Drug Abuse Preven&on Collabora&ve
4 Priority Area Facilitators 4 Priority Area Teams 4 Priority Area Ac&on Plans
Educa&on / Advocacy Safe Storage and Secure Disposal Law Enforcement
Collabora&ve became Policy Educa&on Body as one of its func&ons
Major strides were made in informing policy decisions of the Georgia General Assembly
during their 2013 and 2014 legisla&ve sessions
We clearly defined terms – “Advocacy” used as Umbrella Term
Collabora&ve Members informed about differences between
“Lobbying” and “Policy Educa&on” (See Handout for Defini&ons)
Lobbyists hired as Policy Educa&on Advisors
Policy Advisor created Tips for Communica&ng with Legislators
(see Handout)
Major Tips: 1. You are the rela&ve expert
2. Don’t be afraid to talk to your legislator
In 2013 the Collabora&ve was instrumental in gedng dispenser Prescrip&on Drug Monitoring Program (PDMP) sharing as well as a Pill Mill bill passed.
In 2014 the Ini&a&ve was instrumental in gedng prescriber PDMP sharing passed, helping to keep PDMP from possibly going offline in 2015.
Media Awareness Campaign
Website: www.StopRxAbuseinGA
Drug Drop Box Campaign
The Council on Alcohol and Drugs, with the assistance of DBHDD, planned, funded, directed and executed the successful placement of 139 law enforcement-‐
maintained Rx & OTC drug drop boxes across the state, making Georgia the leader in the
na&on in the number of such drug drop boxes.
What’s in the Water?
The Ini&a&ve will be collabora&ng with the Georgia Water Associa&on to protect Georgia’s public water supply from contamina&on from
prescrip&on drugs.
National Rx Drug Abuse Summit April 23, 2014
Christopher Wood, ICPS Georgia DBHDD/Office of Prevention
Christopher Wood has no financial relationships with proprietary entities
that produce health care goods and services.
Learning Objective: o Identify three policy and/or
programmatic approaches to prevent prescription drug misuse, abuse, and diversion toward the long-term improvement of health outcomes.
o SAMHSA PFS II Grant o High Need/Low Capacity Areas o Objective & Target Populations o Strategies /Approach o ONDCP Rx Plan
o Needs Assessments
Strategies: o Additional Rx Drug Drop Box o Medicine Safes o Parenting Classes o Social Marketing Campaign o Theater Troupe
Strategies: o Multiple Drug Drop Boxes o Pharmacy Sticker Shock o Social Access Campaign o Movie Theater PSA’s
Strategies: o Additional Rx Drug Drop Box o Multiple Take Back Events o “Where’s the Box?” Media Campaign o Water Ways o Rx for Understanding
